home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Tyra Biosciences raises $50M to develop therapies targeting acquired resistance in oncology
Tyra Biosciences raises $50M to develop therapies targeting acquired resistance in oncology
Post navigation
Previous Post
Previous
Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing
Next Post
Next
EQRx Scales Disruptive Model of Important New Medicines at Lower Prices with $500M Series B Financing